Harvey Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,010
| Closed | -$1.57M | – | 78 |
|
|
2024
Q1 | $1.57M | Sell |
29,010
-174
| -0.6% | -$9.44K | 0.46% | 45 |
|
|
2023
Q4 | $1.5M | Sell |
29,184
-27,000
| -48% | -$1.39M | 0.5% | 43 |
|
|
2023
Q3 | $3.26M | Sell |
56,184
-150
| -0.3% | -$8.71K | 1.15% | 26 |
|
|
2023
Q2 | $3.6M | Hold |
56,334
| – | – | 1.32% | 23 |
|
|
2023
Q1 | $3.9M | Buy |
+56,334
| New | +$3.9M | 1.54% | 21 |
|
|
2022
Q2 | – | Sell |
-145,641
| Closed | -$10.6M | – | 77 |
|
|
2022
Q1 | $10.6M | Sell |
145,641
-12,305
| -8% | -$899K | 3.28% | 8 |
|
|
2021
Q4 | $9.85M | Buy |
157,946
+10,180
| +7% | +$635K | 3.05% | 9 |
|
|
2021
Q3 | $8.74M | Buy |
147,766
+690
| +0.5% | +$40.8K | 2.99% | 9 |
|
|
2021
Q2 | $9.83M | Sell |
147,076
-1,875
| -1% | -$125K | 3.24% | 8 |
|
|
2021
Q1 | $9.4M | Buy |
148,951
+3,755
| +3% | +$237K | 3.41% | 7 |
|
|
2020
Q4 | $9.01M | Sell |
145,196
-11,100
| -7% | -$688K | 3.65% | 7 |
|
|
2020
Q3 | $9.42M | Sell |
156,296
-11,738
| -7% | -$708K | 4.2% | 4 |
|
|
2020
Q2 | $9.88M | Buy |
168,034
+4,938
| +3% | +$290K | 4.89% | 5 |
|
|
2020
Q1 | $9.09M | Sell |
163,096
-3,300
| -2% | -$184K | 6.13% | 4 |
|
|
2019
Q4 | $10.7M | Buy |
166,396
+61,596
| +59% | +$3.95M | 4.74% | 6 |
|
|
2019
Q3 | $5.31M | Sell |
104,800
-800
| -0.8% | -$40.6K | 2.64% | 11 |
|
|
2019
Q2 | $4.79M | Buy |
105,600
+101,300
| +2,356% | +$4.59M | 2.3% | 16 |
|
|
2019
Q1 | $205K | Buy |
+4,300
| New | +$205K | 0.1% | 76 |
|